Employees State Insurance Corporation Urethral Catheter Tender in India 2026 MDR 2017 Compliance

Tender Overview

Employees State Insurance Corporation seeks supply of Urethral Catheter under MDR 2017 compliance with valid medical device licensing and IS 18288 packing standards. Estimated value around ₹135,000 for the procurement, with scope limited to the supply of goods. The contract includes a 25% quantity option and a mandatory advance sample approval process within 5 days of award. Delivery timelines adjust if samples face buyer delays, with modification cycles per buyer feedback. Location not disclosed; procurement targets standard medical device shipments to meet clinical needs.

Technical Specifications & Requirements

• Product category: Urethral Catheter (general and product information fields repeated; catheter size, coating, detectability, MRI compatibility, sterility, usage, and patient utility to be met).
• Packing & Marking: per IS 18288 (latest revision).
• Standards & Licenses: MDR 2017 compliance and valid Medical Device license under the Drugs and Cosmetic Act, 1940.
• Shelf life: minimum shelf life required at delivery.
• Sample process: advance samples required; 5 samples for buyer approval; no bulk supply until approved; potential LD waivers if buyer delays approval.
• Delivery scope: pure supply of goods; includes testing at buyer lab where applicable.
• Evidence of compliance: product must meet declared sterility, catheter type, coating, detectability, MRI compatibility, and size specifications as per tender data.

Terms, Conditions & Eligibility

• Option clause: purchaser may alter quantity by ±25% during contract; delivery period adjusts based on added quantity with minimum 30 days.
• Payment & samples: advance sample approval tests; bulk supply only after approval; all material test certificates accompany delivery.
• Documentation focus: bidders must provide GST, PAN, experience evidence, and OEM authorizations if applicable; terms emphasize “Only supply of Goods.”
• Penalties: terms reference potential delays and modifications without LDs depending on buyer actions; advance samples dominate acceptance criteria.